VECT
VectivBio Holding AG
NASDAQ: VECT · HEALTHCARE · PHARMACEUTICALS
$16.85
+0.00% today
Updated 2026-04-30
Market cap
$1.06B
P/E ratio
—
P/S ratio
21.08x
EPS (TTM)
$-2.10
Dividend yield
—
52W range
$0 – $0
Volume
—
VectivBio Holding AG (VECT) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|
| Operating cash flow | $-14.90M | $-38.21M | $-72.14M | $-56.26M |
| Capital expenditures | $56000.00 | $93000.00 | $57000.00 | $74000.00 |
| Depreciation | $152000.00 | $270000.00 | $303000.00 | $239000.00 |
| Stock-based comp | $2.08M | $5.45M | $24.90M | $16.77M |
| Free cash flow | $-14.95M | $-38.30M | $-72.20M | $-56.33M |
| Investing cash flow | $-45000.00 | $-69000.00 | $-6.67M | $-74000.00 |
| Financing cash flow | $32.81M | $56.59M | $141.33M | $175.06M |
| Dividends paid | — | — | — | — |
| Share repurchases | — | — | — | — |
| Debt repayment | — | — | — | — |
| Net change in cash | — | — | — | — |